In addition, transfer of P14 CD8+ Teff that had been pre-cultured with activated CD28KOCD8+ T cells in the presence of ZM241385 (79.5% survival, group IV) also significantly improved the survival of tumor-bearing mice compared to mice in group II (p < 0.01). The gene discussed is CD8A; the disease is neoplasm.